Can I Participate?
You may be eligible to participate in this study if you:

If you or a loved one are living with systemic sclerosis (scleroderma or SSc), consider joining the TibuSURE clinical study where researchers are exploring whether a new study drug could impact disease progression in individuals with systemic sclerosis.
The goal of this study is to determine the safety and effectiveness of tibulizumab and determine whether it affects certain systemic sclerosis signs and symptoms.
You may be eligible to participate in this study if you:
By enrolling in this Phase 2 study, you may participate in a clinical study working to determine if the study drug is able to decrease disease activity in the following ways:
By enrolling in this Phase 2 study, you may receive:
Access to expert physicians with experience managing systemic sclerosis
Travel and accommodation support for study visits
Assessments on your health
The investigational study drug at no cost to you
Insurance is not required to join this study
This website or its third-party tools use cookies, which are necessary for its functioning and required to achieve the purposes illustrated in the cookie policy.
You accept the use of cookies by clicking "I accept", closing or dismissing this notice, scrolling on this page, clicking a link or button on the page, or by continuing to browse otherwise.